Ticker Details
Standard BioTools Inc.
IPO Date:	March 1, 2011
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$367.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 3.95%
Avg Daily Range (30 D):	$0.07 | 6.56%
Avg Daily Range (90 D):	$0.04 | 4.19%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	3.93M
Avg Daily Volume (90 D):	2.86M

Trade Size
Avg Trade Size (Sh.):	205
Avg Trade Size (Sh.) (30 D):	277
Avg Trade Size (Sh.) (90 D):	258

Institutional Trades
Total Institutional Trades:	138
Avg Institutional Trade:	$1.92M
Avg Institutional Trade (30 D):	$5.19M
Avg Institutional Trade (90 D):	$2.4M
Avg Institutional Trade Volume:	1.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.02M
Avg Closing Trade (30 D):	$6.21M
Avg Closing Trade (90 D):	$3.93M
Avg Closing Volume:	2.02M

News

Jun 19, 2026 @ 4:48 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 8, 2026 @ 11:30 AM Standard BioTools and Treeline Biosciences Announc... Source: Na

Apr 21, 2026 @ 11:00 AM Standard BioTools to Announce First Quarter 2026 F... Source: Na

Feb 10, 2026 @ 12:00 PM Standard BioTools to Announce Fourth Quarter and F... Source: Na

Jul 21, 2025 @ 11:00 AM Standard BioTools Schedules Second Quarter Earning... Source: Marissa Bychir

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.2	$.33	$.05
Diluted EPS	$.2	$.33	$.05
Revenue	$86.26M	$21.15M	$23.8M
Gross Profit	$42.8M	$11.31M	$11.38M
Net Income / Loss	$78.21M	$127.07M	$19.28M
Operating Income / Loss	$-95.78M	$-12.5M	$-24.64M
Cost of Revenue	$43.45M	$9.84M	$12.41M
Net Cash Flow	$114.39M	$144.57M	$-8.71M
PE Ratio